Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

News Daily News

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

L.A. McKeown

May 16, 2025

News Daily News

IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication

L.A. McKeown

December 03, 2024

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Conference News SCAI 2024

Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows

L.A. McKeown

May 06, 2024

News Conference News VIVA 2023

PROMISE II: Deep-Vein Arterialization Durable for Amputation-Free Survival in CLTI

L.A. McKeown

November 01, 2023

News Conference News TCT 2022

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

L.A. McKeown

September 17, 2022

News Daily News

VTE Risk Higher With COVID-19 Than With Flu

Todd Neale

August 18, 2022

News Daily News

Select COVID-19 Patients May Benefit From Postdischarge Anticoagulation

Todd Neale

November 25, 2021

News Opinion CV Team Dispatch

July/August 2021 News Roundup

L.A. McKeown

August 01, 2021

News Daily News

Blood Clots After COVID-19 Vaccination Linked to Immune Response: UK Report

Michael O'Riordan

April 16, 2021

News Daily News

Longer Patency, Fewer Repeat Procedures With Paclitaxel DCBs in Dialysis Patients

L.A. McKeown

August 21, 2020

News Daily News

In COVID-19 Pulmonary Embolism, Nontraditional Risk Factors Dominate

Yael L. Maxwell

July 21, 2020

News Conference News ACC 2020

Caravaggio Backs Apixaban for Prevention of VTE Recurrence in Cancer Patients

L.A. McKeown

April 01, 2020

News Conference News ISET 2020

Venous Stents: Long-term Follow-up Plus a New Contender

Caitlin E. Cox

January 24, 2020

News Daily News

Heart Failure Itself, Not Just the Hospital Stay, May Raise Long-term VTE Risk

Caitlin E. Cox

January 14, 2020

News Daily News

FDA: Class I Recall for Cook Medical’s CrossCath Support Catheters

L.A. McKeown

December 17, 2019

News Daily News

Disparities Seen in Uptake of DOACs for VTE

Todd Neale

April 05, 2019

Attacking DVT With Drug-Device Combo Does Not Reduce Postthrombotic Syndrome

News Conference News VIVA 2018

VERNACULAR: A Novel Venous Stent Shows Promise for Treatment of Iliofemoral Occlusive Disease

L.A. McKeown

November 08, 2018

News Daily News

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

L.A. McKeown

November 02, 2018

News Industry News

Venclose Completes Series B Financing and Announces the Appointment of Jeffrey G. Carr, MD as Chief Medical Officer and Gregory J. Vislocky to its Board of Directors

July 11, 2018

Advertisement

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication

November 2024 Dispatch for the CV Team

Women, Black Patients Less Likely to Get Advanced PE Therapy, Analysis Shows

PROMISE II: Deep-Vein Arterialization Durable for Amputation-Free Survival in CLTI

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

VTE Risk Higher With COVID-19 Than With Flu

Select COVID-19 Patients May Benefit From Postdischarge Anticoagulation

July/August 2021 News Roundup

Blood Clots After COVID-19 Vaccination Linked to Immune Response: UK Report

Longer Patency, Fewer Repeat Procedures With Paclitaxel DCBs in Dialysis Patients

In COVID-19 Pulmonary Embolism, Nontraditional Risk Factors Dominate

Caravaggio Backs Apixaban for Prevention of VTE Recurrence in Cancer Patients

Venous Stents: Long-term Follow-up Plus a New Contender

Heart Failure Itself, Not Just the Hospital Stay, May Raise Long-term VTE Risk

FDA: Class I Recall for Cook Medical’s CrossCath Support Catheters

Disparities Seen in Uptake of DOACs for VTE

VERNACULAR: A Novel Venous Stent Shows Promise for Treatment of Iliofemoral Occlusive Disease

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

Venclose Completes Series B Financing and Announces the Appointment of Jeffrey G. Carr, MD as Chief Medical Officer and Gregory J. Vislocky to its Board of Directors

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content